Genetic and clinical analysis in 10 Spanish patients with multiple endocrine neoplasia type 1
Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Beatriz Martínez–Delgado(Centre for Biomedical Network Research on Rare Diseases), Ana Osório(Spanish National Cancer Research Centre), Clotilde Vázquez(Instituto de Salud Carlos III), Juan J. Díez(Instituto Cajal), Jose Luis Herrera-Pombo(Hospital Universitario Fundación Jiménez Díaz), Olga Sánchez-Vilar(Hospital Universitario Fundación Jiménez Díaz), Javier Benítez(Hospital Universitario Virgen del Rocío), Antonio Picó(Hospital General Universitario de Alicante Doctor Balmis), José Ignacio Lara(Hospital Universitario Fundación Jiménez Díaz)
Cited by 13
Related Papers
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
|Human Molecular Genetics|2013|394
Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
|International Journal of Epidemiology|2018|325